The Oesophagus and Oesophageal Disorders

  • Nages Nagaratnam
  • Kujan Nagaratnam
  • Gary Cheuk
Reference work entry

Abstract

The three main symptoms of oesophageal disease or disorder are dysphagia, noncardiac chest pain and heartburn. Oropharyngeal dysphagia and oesophageal dysphagia often present as a symptom of a larger disease process and are a secondary diagnosis. Stroke is a leading cause of oropharyngeal dysphagia. Oesophageal dysphagia is caused by disordered motility or is a result of obstruction to the passage of the food bolus through the oesophagus to the stomach. Oesophageal dysphagia is basically due to either motility disorders (primary or secondary) or to mechanical obstruction (intrinsic or extrinsic). The prevalence of gastro-oesophageal reflux disease (GORD) increases with age and the elderly are more likely to develop severe disease. The greatest concern with GORD is the development of complications. Barrett’s oesophagus is common in the middle-aged and the elderly. The primary goal in the management of GORD is to promote the healing of the damaged oesophagus, by suppression of acid secretion, alleviating the symptoms, and preventing complications. The review summarises the main group of oesophageal disorders with the main focus on their effects and/or adverse effects.

Keywords

Oropharyngeal dysphagia Oesophageal dysphagia Gastro-oesophageal reflux disease Proton-pump inhibitors (PPI) 

References

  1. 1.
    Cook IJ. Normal and disordered swallowing: new insights. Baillieres Clin Gastroenterol. 1991;5(2):245–67.CrossRefPubMedGoogle Scholar
  2. 2.
    Longemann JA. 1983. as quoted by Patrick McCaffrey, CMSD 642 Neuropathologies of swallowing and speech. Unit 4. Physiology of swallowing. http://www.csuchico.edu/~pmccaffrey/syllabi/SPPA342/342unit4.html retrieved 8 January 2008.
  3. 3.
    Longemann JA. 1997 as quoted by Patrick McCaffrey, CMSD 642 Neuropathologies of swallowing and speech. Unit 4. Physiology of swallowing. http://www.csuchico.edu/~pmccaffrey/syllabi/SPPA342/342unit4.html retrieved 8 January 2008.
  4. 4.
    Dodds WJ. The physiology of swallowing. Dysphagia. 1989;3(4):171–178.CrossRefPubMedGoogle Scholar
  5. 5.
    Tack J, Vantrappen G. The aging oesophagus. Gut 1977;41:422–424.CrossRefGoogle Scholar
  6. 6.
    Eslick GD, Fass R. Non cardiac chest pain: evaluation and treatment. Gastroenterol Clin North Am. 2003;32(2): 531–552.CrossRefPubMedGoogle Scholar
  7. 7.
    Wong WM, Lai KC, Lam KF, Hui WM, Hu WH, Lam CL, et al. Prevalence, clinical spectrum and health care utilization of gastrooesophageal reflux disease in a Chinese population: a population based study. Aliment Pharmacol Ther. 2003;18:595–604.CrossRefPubMedGoogle Scholar
  8. 8.
    Eslick GD, Jones MD, Talley NJ. Non cardiac chest pain: prevalence, risk factors impact and consulting-a population based study. Aliment Pharmacol Ther. 2003;17(9): 1115–1124.CrossRefPubMedGoogle Scholar
  9. 9.
    Locke GR 3rd,Talley NJ, Fett SL, Zinmeistr AR, Melton LJ, 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmstead County Minnesota. Gastroenterology. 1997;112(5): 1448–1456.CrossRefPubMedGoogle Scholar
  10. 10.
    Kotzan J Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in Medicated population. Pharm Res. 2001:18(9): 1367–1372.CrossRefPubMedGoogle Scholar
  11. 11.
    Ekberg O, Feinberg MJ. Altered swallowing function in elderly patients without dysphagia: Radiologic findings in 56 cases. AJR. 1991; 156:1181–1184.CrossRefPubMedGoogle Scholar
  12. 12.
    Khan TA, Shragge BW, Crispin JS, Lind JF. Esophageal motility in the elderly. Am J Dig Dis. 1977.22:10–14.CrossRefGoogle Scholar
  13. 13.
    Longemann JA. Swallowing physiology and pathophysiology. Otolaryngol Clin North Am 1988;21(4):613–23.Google Scholar
  14. 14.
    Ergun GA, Miskovitz PF. Aging and the oesophagus: common pathologic conditions and their swallowing in the geriatric population. Dysphagia. 1992;7(2):58–63.CrossRefPubMedGoogle Scholar
  15. 15.
    Mujica VR, Conklin J. When it’s hard to swallow. What to look for in patients with dysphagia. Postgrad Med. 1999;105(7):131–4., 141–2, 145.CrossRefPubMedGoogle Scholar
  16. 16.
    Robinson DJ, Jerrad-Dunne P, Greene Z, Lawson S, Lane S, O’Neill D. Oropharyngeal dysphagia with exacerbation of chronic obstructive pulmonary disease. Eur Geriatr Med. 2011; 2($):201–203.CrossRefGoogle Scholar
  17. 17.
    Patient.co.uk. Bulbar and pseudobulbar palsy. http://www.patient.co.uk/doctor/Bulbar-and Pseudobulber-Palsy.htm retrieved 7 January 2015.
  18. 18.
    Martino R, Foley N, Bhogal S, Diamot N, Speechley M, Teasell R. Dysphagia after stroke: incidence diagnosis and pulmonary complications. Stroke. 1005;36(2):2756–63.Google Scholar
  19. 19.
    Falsetti P, Accrai C, Palilla R, Bosi M, Carpinteri F, ZIngarelli A, et al. Oropharyngeal dysphagia after stroke: incidence diagnosis and clinical predictions in patients admitted to a neurorehabilitation unit. J Stroke Cerebrovasc Dis. 2009;18(5):329–31.CrossRefPubMedGoogle Scholar
  20. 20.
    Watenberg S, Landau O, Avrahami R. Zenker’s diverticulum: a re-appraisal. Am J Gastrenterol. 1990;91:1494–1496.Google Scholar
  21. 21.
    Kouffman JA, Amin MR, Panetti H. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg. 2000;123:385–8.CrossRefGoogle Scholar
  22. 22.
    Lam P, Wei WI, Hui Y, Ho W-K. Prevalence of pH documented laryngopharyngeal reflux in Chinese patients with clinical suspected reflux laryngitis. Am J Oto Laryngol Head Neck Med Surg. 2006;127:186–189.Google Scholar
  23. 23.
    Copper MP, Smith CF, Stanojcic LD, Deviesse PP, Schonwenburg PF, Mathus-Vliegen LM, et al. High incidence of laryngopharyngeal reflux in patients with head and neck cancer. Laryngoscope. 2000;111:1007–11.CrossRefGoogle Scholar
  24. 24.
    Kouffman JA. The otolaryngologic manifestation of gastro-esophageal reflux disease: a clinical investigation of 225 patients with ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin on the development of laryngeal injury. Laryngoscope. 1991;101(4):pt2 Suppl (53)1–78.Google Scholar
  25. 25.
    Ross JA, Noordzji JP, Woo P. Voice disorders in patients suspected laryngopharyngeal reflux disease. J Voice. 1998;12:84–88.CrossRefPubMedGoogle Scholar
  26. 26.
    Chen MY, Ott DJ, Cosolo BT, Moghazy KM, Koufma JA. Correlation of laryngeal and pharyngeal carcinomas and 24 hr pH of the oesophagus and pharynx. Otolaryngol Head Neck Surg. 1998;119:460–462.PubMedGoogle Scholar
  27. 27.
    Landler V, Hollwarth ME, Uroy E, Schober PH, Reiterer F, Schenkili R. Esophageal function infants and sudden infant death risk. Clin Peadiatr. 1990;202(1):37–42.Google Scholar
  28. 28.
    Nelson JB, Castell DO. Esophageal motility disorders. Dis Mon 1988;34:297–398.CrossRefPubMedGoogle Scholar
  29. 29.
    Adler DG, Romero Y. Primary esophageal motility disorders. Mayo Clin Proc. 2001;76:195–200.CrossRefPubMedGoogle Scholar
  30. 30.
    Richter J. Oesophageal motility disorders. The Lancet. 2003;358:823–828.CrossRefGoogle Scholar
  31. 31.
    Walzer N, Hirano I. Achalasia. Gasteroenterol Clin North Am. 2008;37(4):807–25.CrossRefGoogle Scholar
  32. 32.
    Hirano I. Pathophysiology of achalasia. Curr Gastroenterol Rep 1999/1(3):198–202.CrossRefPubMedGoogle Scholar
  33. 33.
    Spirandio M, Tutuian R, Gideon R M. Diffuse oesophageal spasm: not diffuse but distal oesophageal spasm (DES) Dig Dis Sci. 2003;48(7):1380–4.CrossRefGoogle Scholar
  34. 34.
    Roman S, Kahrilas PJ. Distal oesophageal spasm. Dysphagia. 2012;27(1): 115–23.CrossRefPubMedGoogle Scholar
  35. 35.
    Bennett J. ABC of upper gastrointestinal tract: oesophagus: atypical chest pain and motility disorders. BMJ. 2001;323:791–4.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Thompson A. Esophageal sphincter. e Medicine.com 2006.Google Scholar
  37. 37.
    Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastroesophageal reflux disease: a systematic review. Gut. 2005;54:710–717.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Mahadeva S, Raman MC, Ford AC, Follows M, Axon AJ, Goh KL, et al. Gastro-oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South Eastern patients with dyspepsia. Alimen Phamacol Ther 2005;21:1483–1490.CrossRefGoogle Scholar
  39. 39.
    Chen T, La M, Wang X, Yang Y, Zhang J, Jin L, et al. Prevalence and risk factors of gastro-oesophageal reflux disease in Chinese retiree cohort. BMC Gastroenterol. 2012;15:12:161.doi  https://doi.org/10.1186/1471-230X-12-161.
  40. 40.
    Sharma PK, Ahuja V, Madan K, Gupta S, Raizade A, Sharma MP. Prevalence, severity and risk factors of symptomatic gastro-oesophageal reflux disease among in a large hospital in Northern India. Ind J Gastroenterol. 2011;30(3):128–34.CrossRefGoogle Scholar
  41. 41.
    Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux disease symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther. 2000;14:1594–1589.CrossRefGoogle Scholar
  42. 42.
    Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-esophageal reflux disease in an adult population. Ann Med. 1995:27:67–70.CrossRefPubMedGoogle Scholar
  43. 43.
    Ohman L, Olofsson J, Tibbling L, Ericsson G. Esophageal dysfunction in patients with contact ulcer of the larynx. Ann Otol Rhinol Laryngol. 1983;92:228–230.CrossRefPubMedGoogle Scholar
  44. 44.
    Harding SM, Richter JE. The role of gastroesophageal reflux in chronic cough and asthma. Chest. 1997;111:1389–402CrossRefPubMedGoogle Scholar
  45. 45.
    e Vault KR. Extra oesophageal symptoms of gastro esophageal reflux disease. Clev Clin J Med. 2003;70:S20–S32.Google Scholar
  46. 46.
    Pilotto A. Aging and upper gastrointestinal disorders. Best Pract Res Clin Gastrenterol. 2004;18Suppl:73–81.Google Scholar
  47. 47.
    De Vault KR. Alarm symptoms in gastro-oesophageal reflux disease. Medscape Family Medicine. www.medscape.com/view articles.464186, 2003.
  48. 48.
    Gastroenterological Society of Australia. Gastroesophageal reflux disease in adults. Guidelines for clinicians 3rd ed 2001. available at www.gesa.org.au/members_guidelines/govcflux/index.htm
  49. 49.
    Armstrong, D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmichi JP, et al. The endoscopic assessment of oesophagitis: a progress report on observer agreement. Gastroenterology. 1996;13(1):85–92.CrossRefGoogle Scholar
  50. 50.
    Armstrong D, Emde C, Inauen W, Blum A. Diagnostic assessment of gastrointestinal reflux disease: what is possible vs what is practical? Hepatogastroenterology. 1992;suppl 1:3-13c.Google Scholar
  51. 51.
    Pettit M. treatment of gastroesophageal reflux disease. Pharm World Sci. 2005;27(6):432–5.CrossRefPubMedGoogle Scholar
  52. 52.
    Brady WM, Ogorek CP. Gastroesophageal reflux disease. The long and short of therapeutic options. Postgrad Med. 1996;100(5):76–80., 85-6,89.CrossRefPubMedGoogle Scholar
  53. 53.
    Lowe RC. Medical management of gastroesophageal reflux disease. GI Motility. online 2006.  https://doi.org/10.1038/gimo54 published 16 May 2006.
  54. 54.
    Maton PN. Profile and assessment of Gastroesophageal reflux disease pharmacotherapy. Cleve Clin J Med. 2003:70 suppl5:S51–70.CrossRefPubMedGoogle Scholar
  55. 55.
    Treating GERD. http://heartburn.about.com/od/geracidrefluxdisease/a/treating.gerd.htm. Sharon Gillson. Updated April 18, 2008. assessed Nov 21 1012.
  56. 56.
    Robinson M, Horn J. Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know. Drugs. 2003;63(24):2739–54.CrossRefPubMedGoogle Scholar
  57. 57.
    De Korwin JD, Ducrotte P, Vallot T. New generation proton pump inhibitors: progress in the treatment of peptic acid disease? Presse Med. 2004;33(11):746–54.CrossRefPubMedGoogle Scholar
  58. 58.
    Sontag SJ, Hirschowitz BI, Holt S, Robinson MG, Behar J, Berenson MM, et al. Two doses of omeprazole versus placebo in symptomatic erosive oesophagitis: the US Multicenter study. Gastronterology. 1992;102(11): 109–118.CrossRefGoogle Scholar
  59. 59.
    Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM. Efficiency and safety of lansoprazole in treatment of erosive reflux oesophagitis. The Lansoprazole Group. Am J Gastroenterol; 1996;91 (9) 1749–1757.PubMedGoogle Scholar
  60. 60.
    Richter TE, Bochinik K. Oral pantoprazole for erosive oesophagitis: a placebo controlled randomized clinical trial. Pantoprazole US Gastrooesophageal Reflux Disease Study Group. Am J Gastroenterol. 2000;95(11):3071–3080.CrossRefPubMedGoogle Scholar
  61. 61.
    American Gastroenterological Association Institute technical review in the management of gastroesophageal reflux disease. Gastroenterology. 2008;135: 1392–1413.Google Scholar
  62. 62.
    Katsanos KH, Tasolambron C, Christodoulopoulou A, et al. Comparison of the ‘step down’ and ‘step up’ approach in the treatment in the treatment of patients with symptomatic gastroesophageal reflux disease (GERD) with results of a randomized open-label pilot study with omeprazole in Northwest Greece. Annals Gastroenterol. 2003;16(2):138–150.Google Scholar
  63. 63.
    Lux G, Bozkurt T, Orth HK. Gastrointestinal motility in the elderly. Z Gerontol. 1992; 25(5):295–303.PubMedGoogle Scholar
  64. 64.
    Matsuda NM, Miller SM, Evora PRB. The chronic gastrointestinal manifestations of Chagas disease. Clinics (Sao Paulo). 2009;64(12):1219–1224.CrossRefGoogle Scholar
  65. 65.
    Iantorno G, Basotti G, Kogan Z, Lumi CM, Cabanne AM, Fisogni S, et al. The enteric nervous system in chagasic and idiopathic megacolon. Am J Surg Pathol. 2007;31:460–8.CrossRefPubMedGoogle Scholar
  66. 66.
    Thornhill C. New GERD algorithm published. Aliment Pharmacol Ther 2008;27:249–256.Google Scholar
  67. 67.
    Stavarou EP, McElroy HJ, Baker DF, Smith G, Bishop JF Adenocarcinoma of the oesophagus; incidence and survival rates in New South Wales 1972–2005. Med J Aust. 2009;191:310–314.Google Scholar
  68. 68.
    Smithers BM, Fahey PP, Covish T, Golley DC, Falk GL, Smith GC, et al. Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia. Med J. Aust 2010;193 (10):572–577.PubMedGoogle Scholar
  69. 69.
    Cameron AJ. Epidemiological studies in the development of Barrett’s oesophagus. Endoscopy. 1993; 25:635.CrossRefPubMedGoogle Scholar
  70. 70.
    Schlachta CM, Poulin EC, Mamazza J, Seshadri PA. Peptic strictures of the oesophagus. In: Holzheimer RG, Mannick JA.editors. Surgical Treatment: Evidenced – based Problem orientated. Munich: Zuckschwerdt. 2001. http://www.nch.nim.nih.gov/books/NBK6899/ retrieved 1 October 2014.
  71. 71.
    Baker ME, Zuccaro G Jr, Achliar E, Rice TW. Esophageal diverticular patient assessment. Semin Thorac Cardiovasc Surg. 1999;11(4):326–36.CrossRefPubMedGoogle Scholar
  72. 72.
    Lind CD. Dysphagia: evaluation and treatment. Gastrenterol Clin North Am. 2003;32(2):553–75.CrossRefGoogle Scholar
  73. 73.
    Marshall JB. Dysphagia, pathophysiology, causes and evaluation. Postgrad Med 1985;77(5):58–63., 67–8 .CrossRefPubMedGoogle Scholar
  74. 74.
    Gisbert JP, Cooper A, Karagiannio D, Hatlebakk J, Agreus L, Jablonowski H, et al. Impact of gastrointestinal related disease on patient’s daily lives: a European observational studies in primary care setting. Health and Quality Outcomes. 2009:7:60.  https://doi.org/10.1186/1477-7525-7-60.
  75. 75.
    Revick DA, Wood M, Matton PN, Sorensen S. The impact of gastrooesophageal reflux disease on health related quality of life. Am Med J. 1998;104(3):252–8.CrossRefGoogle Scholar
  76. 76.
    Shaw MJ, Crawley JA. Improving HR-QoL in gastrooesophageal reflux disease. Drugs. 2003;63(21):2307–16.CrossRefPubMedGoogle Scholar
  77. 77.
    Ponce J, Beltran B, Ponce M, Zaperdiel J, Oritz V, Vegizo O, et al. Impact of gord on quality of life of Spanish patients: the relevance of the biometric factors and severity of symptoms. Eur J Gastroenterol Hepatol. 2009;21(6):620–9.CrossRefPubMedGoogle Scholar
  78. 78.
    Kamaolz T, Pointner R, Velanovich V. Impact of GORD on Quality of life: Review of literature. Surg Endosc. 2003;17:1193–1199.CrossRefGoogle Scholar
  79. 79.
    Velanovich V. Quality of Life and severity of symptoms in gastrooesophageal reflux disease: a clinical review. Eur J Surg. 2000;160(7):516–25.CrossRefGoogle Scholar
  80. 80.
    Prasad M, Rentz AM, Revick DA. The impact of treatment for gastro oesophageal reflux disease on HR-QOL: A literature review. Pharmacoeconomics. 2013;21(11):769–90.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nages Nagaratnam
    • 1
  • Kujan Nagaratnam
    • 1
  • Gary Cheuk
    • 2
  1. 1.The University of SydneyWestmead Clinical SchoolWestmeadAustralia
  2. 2.Rehabilitation and Aged Care ServiceBlacktown-Mt Druitt HospitalMount DruittAustralia

Personalised recommendations